Hope in Focus to Host LCA Family Conference June 23-24
/PRNewswire/ -- Hope in Focus, a nonprofit dedicated to finding treatments and cures for blindness caused by rare inherited retinal diseases, presents its 2023...
Stay updated with breaking news from Sofia Sees Hope. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hope in Focus, a nonprofit dedicated to finding treatments and cures for blindness caused by rare inherited retinal diseases, presents its 2023...
Mystic — A local grassroots group, whose 117 members meet quarterly to pool their $100 contributions, has now awarded almost $200,000 to area organizations. Power of Together 2, which formed in 2016 as an offshoot of a similar East-Lyme based group, made its latest donation — $10,700 — to FRESH New London last Friday. Gae Melford, one of the group's organizers and co-founders, said that while people may donate $50 or $100 on their own to a local organization, they can have a larger impact if they pool their donations. "It's exciting that you can raise $11,000 in an hour," she said...
Published January 18. 2021 5:08PM | Updated January 19. 2021 9:22AM Ledyard — Sofia Sees Hope, a locally based nonprofit, will donate $72,000 to support research into treatments for inherited retinal diseases and to provide free access to genetic testing for those with IRDs. The coronavirus pandemic last year forced the organization to cancel its main fundraising event, Dinner in the Dark, a well-attended dinner that has raised nearly $200,000 in previous years. “We’re grateful that we still had a pretty successful year,” Laura Manfre, the organization’s co-founder and board pres...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10 ProQR Therapeutics N.V.January 7, 2021 GMT Top-line results expected H1 2022 Sepofarsen is a potential first-in-class RNA therapy for the treatment of LCA10, a rare inherited retinal disorder that leads to blindness LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t...